Anemia, Iron-Deficiency — the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients
Citation(s)
Brugnara C A hematologic "gold standard" for iron-deficient states? Clin Chem. 2002 Jul;48(7):981-2.
Joseph B, Ramesh N Weekly dose of Iron-Folate Supplementation with Vitamin-C in the workplace can prevent anaemia in women employees. Pak J Med Sci. 2013 Jan;29(1):47-52. doi: 10.12669/pjms.291.3016.
McCarley P The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses. Nephrol Nurs J. 2006 Jul-Aug;33(4):423-6, 445; quiz 427-8.
Okam MM, Koch TA, Tran MH Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016 Jan;101(1):e6-7. doi: 10.3324/haematol.2015.129114. Epub 2015 Oct 30. Review.
Parveen N, Ahmad S, Shadab GG Iron induced genotoxicity: attenuation by vitamin C and its optimization. Interdiscip Toxicol. 2014 Sep;7(3):154-8. doi: 10.2478/intox-2014-0021. Epub 2014 Dec 30.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
